Showing results (141-150 of 161) with videos related to
Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2000
Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancerD Kaufman, D Raghavan, M Carducci, et al.British Journal of Urology|June 1, 1988
Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been definedD Raghavan, B Colls, J Levi, et al.European Journal of Cancer & Clinical Oncology|July 1, 1989
Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, J Bishop, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
A randomized trial of cisplatin versus cisplatin plus methotrexate in advanced cancer of the urothelial tractB L Hillcoat, D Raghavan, J Matthews, et al.Thorax|May 1, 1985
Cisplatin, vinblastine, and bleomycin in inoperable non-small cell lung cancerR Stuart-Harris, R M Fox, D Raghavan, et al.Australian and New Zealand Journal of Medicine|June 1, 1987
Chemotherapy for small cell lung cancer: induction and reinduction with VOCAR Stuart-Harris, D Raghavan, R M Fox, et al.The Journal of Urology|October 12, 2005
Phase II trial of tesmilifene plus mitoxantrone and prednisone for hormone refractory prostate cancer: high subjective and objective response in patients with symptomatic metastasesD Raghavan, L J Brandes, K Klapp, et al.British Journal of Urology|August 1, 1992
Initial combination chemotherapy with cisplatin, methotrexate and vinblastine in locally advanced transitional cell carcinoma--response rate and pitfalls. MRC Subgroup in Advanced Bladder Cancer (on behalf of the MRC Urological Working Party)S D Fosså, S J Harland, S B Kaye, et al.British Journal of Urology|June 1, 1991
Neo-adjuvant (pre-emptive) cisplatin therapy in invasive transitional cell carcinoma of the bladderD M Wallace, D Raghavan, K A Kelly, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1993
The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Raghavan, V Harvey, et al.Pageof 17